GLENWOOD, Ill., Oct. 4, 2012 /PRNewswire/ -- Landauer, Inc. (NYSE: LDR), a recognized leader in personal and environmental radiation measurement and monitoring, outsourced medical physics services and high quality medical consumable accessories, today announced that it appointed Greg Groenke to President of Landauer's IZI Medical Products business effective immediately.
"Greg is an experienced healthcare professional with a proven track record of leadership and strong operating results," said Bill Saxelby, President and Chief Executive Officer of Landauer, Inc. "Greg's demonstrated proficiency in strategy and product development, along with his medical device regulatory and manufacturing experience within the surgical, orthopedic spine and interventional radiology segments, will enable him to make an immediate impact on our organization."
In this role, Mr. Groenke will set and lead the strategic and operating direction for the IZI Medical Products business. Prior to Landauer, Mr. Groenke served as Senior Vice President/General Manager of Environmental Technologies at Cardinal Health, where he was responsible for a $650 million global business. He has extensive experience in medical device product development and was responsible for business development earlier in his career with Cardinal Health. Prior to joining Cardinal Health, Greg worked for Johnson and Johnson's Ethicon Endo – Surgery business.
Mr. Groenke earned a Master in Business Administration from The University of Minnesota's Carlson School of Management and a Bachelor of Mechanical Engineering from The University of Minnesota."Landauer is a world leader in radiation science and services, and I am delighted to join such a dynamic, innovative company," said Mr. Groenke. "I believe there are extraordinary opportunities to grow and build shareholder value as we achieve our strategic growth initiatives. I look forward to working closely with the IZI employees, as well as our customers, shareholders and business partners."
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts